Clinical Trial Update: Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating preoperative and postoperative sublingual misoprostol to prevent postpartum blood loss during cesarean section has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Postpartum Hemorrhage Prevention

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Assiut University | Conditions: Postpartum Hemorrhage | Phase 4 | Status: COMPLETED